Regio- and Stereoselective Synthesis of α-Chiral 2-Substituted 4-Bromo­thiazoles from 2,4-Dibromothiazole by Bromine-Magnesium Exchange. ­Building Blocks for the Synthesis of Thiazolyl Peptides and Dolabellin

Abstract

Fragment 6 of thiazolyl peptide GE 2270 D2 and fragment 11 of dolabellin were synthesized stereoselectively from 2,4-dibromothiazole (1) in three (6, 44% overall yield) and five synthetic steps (11, 63% overall yield). Key to the success of the strategy was a bromine-magnesium exchange, which proceeds with excellent regio- and chemoselectivity at carbon atom C-2 of 1.

asymmetric synthesis - magnesium - metalations - natural products - thiazoles

References

General reviews on thiazoles:

1a Kikelj D. Urleb U. In Science of Synthesis, Houben-Weyl Methods of Molecular Transformations   Vol. 11:  Schaumann E. Thieme; Stuttgart: 2002.  p.627 

1b Liebscher J. In Houben-Weyl Methoden der Organischen Chemie   4th Ed., Vol. E 8b:  Schaumann E. Thieme; Stuttgart: 1994.  p.1 

1c Dondoni A. Merino P. In Comprehensive Heterocyclic Chemistry II   Vol. 3:  Katritzky AR. Rees CW. Scriven EFV. Bird CW. Pergamon; Oxford: 1996.  p.373 

1d Metzger JV. In Comprehensive Heterocyclic Chemistry   Vol. 6:  Katritzky AR. Rees CW. Bird CW. Cheeseman GWH. Pergamon; Oxford: 1984.  p.235 

Selected examples:

2a Buchanan JL. Bohacek RS. Luke GP. Hatada M. Lu X. Dalgarno DC. Narula SS. Yuan R. Holt DA. Bioorg. Med. Chem. Lett.  1999,  9:  2353 

2b Bagley MC. Bashford KE. Hesketh CL. Moody CJ. J. Am. Chem. Soc.  2000,  122:  3301 

2c Xia Z. Smith CD. J. Org. Chem.  2001,  66:  3459 

2d Lee CB. Wu Z. Zhang F. Chappell MD. Stachel SJ. Chou T.-C. Guan Y. Danishefsky SJ. J. Am. Chem. Soc.  2001,  123:  5249 

2e Cetusic JRP. Green FR. Graupner PR. Oliver MP. Org. Lett.  2002,  4:  1307 

Selected examples:

3a Wipf P. Venkatraman S. J. Org. Chem.  1996,  61:  8004 

3b Heck S. Dömling A. Synlett  2000,  424 

3c Boden CDJ. Pattenden G. J. Chem. Soc., Perkin Trans. 1  2000,  875 

3d Frontrodona X. Diaz S. Linden A. Villalgordo JM. Synthesis  2001,  2021 

3e Sugiyama H. Yokokawa F. Shioiri T. Tetrahedron  2003,  59:  6579 

4 Reynaud P. Robba M. Moreau RC. Bull. Soc. Chim. Fr.  1962,  1735 

5a Bach T. Heuser S. Tetrahedron Lett.  2000,  41:  1707 

5b Bach T. Heuser S. Angew. Chem. Int. Ed.  2001,  40:  3184 

5c Bach T. Heuser S. J. Org. Chem.  2002,  67:  5789 

5d Bach T. Heuser S. Chem.-Eur. J.  2002,  8:  5585 

5e Bach T. Heuser S. Synlett  2002,  2089 

6 Spieß A. PhD Thesis   Technical University; Munich: 2003. 

7a Amouroux R. Axiotis GP. Synthesis  1981,  270 

7b Chastrette M. Axiotis GP. Synthesis  1980,  889 

8a Dondoni A. Fantin G. Fogagnolo M. Medici A. Pedrini P. J. Org. Chem.  1988,  53:  1748 

8b Kelly TR. Jagoe CT. Gu Z. Tetrahedron Lett.  1991,  32:  4263 

8c Nickson TE. J. Fluorine Chem.  1991,  55:  173 

8d Nicolaou KC. He Y. Roschangar F. King NP. Vourloumis D. Li T. Angew. Chem. Int. Ed.  1998,  37:  84 

8e Ung AT. Pyne SG. Tetrahedron: Asymmetry  1998,  9:  1395 

9 Abarbri A. Thibonnet J. Berillon L. Dehmell F. Rottländer M. Knochel P. J. Org. Chem.  2000,  65:  4618 

10 Selva E. Ferrari P. Kurz M. Tavecchia P. Colombo L. Stelle S. Restelli E. Goldstein BP. Ripamonti F. Denaro M. J. Antibiot.  1995,  48:  1039 

11a Okumura K. Saito H. Shin C. Umemura K. Yoshimura J. Bull. Chem. Soc. Jpn.  1998,  71:  1863 

11b Okumura K. Suzuki T. Shin C. Heterocycles  2000,  53:  765 

12 Brussee J. Loos WT. Kruse CG. van der Gen A. Tetrahedron  1990,  46:  979 

13 Brussee J. Dofferhoff F. Kruse CG. van der G en A. Tetrahedron  1990,  46:  1653 

14

Procedure for the Conversion 1→4: At 0 °C, 6.60 mL (12.0 mmol) of a 1.80 M i-PrMgBr solution in Et₂O was added dropwise to a solution of 2.92 g (12.0 mmol) 2,4-dibromothiazole in 30 mL of THF and the solution was stirred for 15 min at 0 °C. Neat TBS-protected mandelo-nitrile [12] (2.47 g, 10.0 mmol) was added dropwise. The mixture was stirred for 30 min at 0 °C and for another 30 min at r.t. After adding 10 mL of EtOH the reaction mixture was cooled to -78 °C and NaBH₄ (0.76 g, 20.0 mmol) was added carefully in small portions. The mixture was stirred for 2 h at -78 °C and - after removing the cooling bath - over night at r.t. The reaction mixture was quenched with 25 mL of sat. aq NH₄Cl solution and diluted with 200 mL Et₂O. The organic layer was washed with 200 mL H₂O and 100 mL brine and it was subsequently dried over Na₂SO₄. GC analysis indicated a facial diastereoselectivity of 79:21. After filtration the solvent was removed and the residue was purified by flash chromatography (pentane/Et₂O: 75:25→50:50). Compound 4 (2.55 g, 6.18 mmol, 62%) was obtained as a yellow liquid. [α]_D ²⁰ -47.9 (c 1.5, CHCl₃). ¹H NMR (360 MHz, CDCl₃): δ = -0.21 (s, 3 H), -0.06 (s, 3 H), 0.82 (s, 9 H), 2.02 (br s, 2 H), 4.41 (d, ³ J = 5.9 Hz, 1 H), 5.04 (d, ³ J = 5.9 Hz, 1 H), 7.09 (s, 1 H), 7.19-7.26 (m, 5 H). ¹³C NMR (90 MHz, CDCl₃): δ = -5.3, -4.8, 18.0, 25.7, 60.6, 78.2, 117.0, 124.3, 127.0, 128.0, 128.1, 140.1, 173.9. Anal. Calcd for C₁₇H₂₅BrN₂OSSi (413.45): C, 49.39; H, 6.09; N, 6.78. Found: C, 49.45; H, 6.11; N, 6.71. The erythro-diastereoisomer (0.47g, 1.13 mmol, 11%) was obtained as a yellow liquid.

15

The relative configuration was proven by converting the aminoalcohol 4 and its erythro-diastereoisomer into the corresponding cyclic N-Boc protected N,O-acetals which were studied independently by ¹H NMR spectroscopy. In addition, a known acetal [11] was prepared by carboxylation of product 5 at carbon atom C-4 (t-BuLi, CO₂ in Et₂O), transformation into the corresponding ester (EtI in DMF), TBS-deprotection (TBAF in THF) and acetal formation (2,2-dimethoxypropane, TsOH in CH₂Cl₂). The enantiomeric excess (95% ee) was determined by HPLC analysis of the N-Boc protected product 5 (column: Machery-Nagel, Nucleodex β-OH, 200 × 4.00 mm; eluent: H₂O/MeCN 20:80→0:100 over 30 min; flow rate: 1.0 mL/min).

16 Sone H. Kondo T. Kiryu M. Ishiwata H. Ojika M. Yamada K. J. Org. Chem.  1995,  60:  4774 

17 Corey EJ. Shibata S. Bakshi RK. J. Org. Chem.  1988,  53:  2861 

18

Analytical data of compound 8: [α]_D ²⁰ +27.5 (c 0.80, CHCl₃). ¹H NMR (360 MHz, CDCl₃): δ = 0.92 (d, ³ J = 6.8 Hz, 3 H), 1.02 (d, ³ J = 6.8 Hz, 3 H), 2.14-2.30 (m, 1 H), 2.60 (br s, 1 H), 4.80 (d, ³ J = 4.8 Hz, 1 H), 7.19 (s, 1 H). ¹³C NMR (90 MHz, CDCl₃): δ = 16.2, 18.8, 34.9, 76.4, 116.7, 124.3, 175.6. Anal. Calcd for C₇H₁₀BrNOS (236.13): C, 35.61; H, 4.27; N, 5.93. Found: C, 35.81; H, 4.38; N, 5.87.

19

Analytical data of compound 11: [α]_D ²⁰ +26.9 (c 1.15, CHCl₃). ¹H NMR (360 MHz, CDCl₃): δ = 0.93 (d, ³ J = 6.6 Hz, 3 H), 1.03 (d, ³ J = 7.0 Hz, 3 H), 2.08 (br s, 1 H), 2.20-2.35 (m, 1 H), 3.94 (s, 3 H), 4.82 (d, ³ J = 4.8 Hz, 1 H), 8.16 (s, 1 H). ¹³C NMR (90 MHz, CDCl₃): δ = 16.2, 18.9, 35.0, 52.4, 76.7, 127.6, 146.4, 161.9, 175.7. Anal. Calcd for C₉H₁₃NO₃S (215.27): C, 50.21; H, 6.09; N, 6.51. Found: C, 49.91; H, 6.20; N, 6.29.